Just read on the japantoday website that they are running very low on Tamiflu - Japan is currently responsible for 60% of worldwide Tamiflu sales, but their demand for the product can't be met.
Subject again to supply constraints on Relenza being overcome, you would think another huge market will open up shortly.
http://www.japantoday.com/e/?content=feature&id=1013
